CTN 222

Studies

The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.

Enrolling

Treatment & Management

Atlantic Region

BC & Yukon Region

Ontario Region

Prairies Region

Québec Region

CTN 222: Canadian co-infection cohort
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients

Publications

Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients

2016

Related Study:

CTN 222

View Publication
Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?

2020

Related Study:

CTN 222

View Publication
DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people

2023

Related Study:

CTN 222

View Publication

Careers

Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.

Learn More

CTN 222

Studies

CTN 222: Canadian co-infection cohort

Publications

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients

Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression?

DAA-mediated HCV cure reduces HIV DNA levels in HCV/HIV coinfected people

Careers